Zhiren Wang

Affiliations: 
2019- College of Pharmacy University of Arizona, Tucson, AZ 
Google:
"Zhiren Wang"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang Z, Li W, Jiang Y, et al. (2024) Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature Communications. 15: 2073
Wang Z, Li W, Jiang Y, et al. (2024) Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy. Biomaterials. 306: 122477
Wang Z, Li W, Jiang Y, et al. (2023) Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy. Nature Communications. 14: 7235
Wang Z, Gonzalez KM, Cordova LE, et al. (2023) Nanotechnology-empowered therapeutics targeting neurodegenerative diseases. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1907
Wang Z, Cordova LE, Chalasani P, et al. (2022) Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy. Molecular Pharmaceutics. 19: 4665-4674
Wang Z, Li W, Park J, et al. (2022) Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 929-939
Wang Z, Little N, Chen J, et al. (2021) Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nature Nanotechnology
Wang Z, Chen J, Little N, et al. (2020) Self-assembling Prodrug Nanotherapeutics for Synergistic Tumor Targeted Drug Delivery. Acta Biomaterialia
Deng J, Peng M, Wang Z, et al. (2018) Novel Application of Metformin Combined with Targeted Drugs on Anticancer Treatment. Cancer Science
See more...